View More Recent Stories
-
TD Cowen Reiterates Buy Rating on Lantheus Holdings (LNTH)
-
Lantheus Holdings (LNTH) Appoints Julie Eastland to its Board
-
Redburn-Atlantic Starts Lantheus Holdings (LNTH) at Buy
-
Lantheus Holdings (LNTH) Misses Q2 EPS by 3c, provides guidance
-
JMP Securities Reiterates Market Outperform Rating on Lantheus Holdings (LNTH)
-
Lantheus Holdings (LNTH) PT Raised to $145 at TD Cowen
-
Lantheus Holdings (LNTH) PT Raised to $137 at Jones Trading
-
Lantheus Holdings (LNTH) Acquires NAV-4694
-
Lantheus Holdings (LNTH) PT Raised to $165 at Mizuho
-
Lantheus Holdings (LNTH) PT Raised to $165 at Mizuho
-
Lantheus Holdings (LNTH) PT Raised to $141 at Truist Securities
-
Truist Securities Reiterates Buy Rating on Lantheus Holdings (LNTH)
-
Lantheus Holdings (LNTH) July 100 calls and August 95 calls as share price up 29%
-
Lantheus Holdings (LNTH) Appoints Jamie Spaeth as Chief People Officer
-
Lantheus Holdings (LNTH) Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

